| |
| |
|
| Insider
Information: |
Gagnon Robert E. |
| Relationship: |
Director |
| City: |
Weston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
359,945 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,893,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
359,945 |
|
|
| Total
Value |
$3,893,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
12
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 234.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
Premium* |
|
|
Clean Harbors Inc |
CLH |
EVP CFO and Treasurer |
2012-09-11 |
7,386 |
2012-09-11 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Chief Financial Officer |
2018-08-29 |
321,169 |
2014-06-16 |
0 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2024-03-19 |
27,391 |
2018-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-13 |
4 |
AS |
$5.25 |
$5,576 |
D/D |
(1,062) |
382,450 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-19 |
4 |
AS |
$5.25 |
$5,775 |
D/D |
(1,100) |
381,350 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-23 |
4 |
AS |
$5.25 |
$7,691 |
D/D |
(1,465) |
379,885 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-24 |
4 |
AS |
$5.25 |
$29,243 |
D/D |
(5,570) |
374,315 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-10 |
4 |
AS |
$5.38 |
$73,706 |
D/D |
(13,700) |
411,857 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-09 |
4 |
AS |
$5.41 |
$76,822 |
D/D |
(14,200) |
411,857 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-27 |
4 |
AS |
$5.54 |
$346,328 |
D/D |
(62,514) |
361,801 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-08-03 |
4 |
D |
$5.70 |
$29,469 |
D/D |
(5,170) |
330,058 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-08-29 |
4 |
S |
$5.77 |
$51,290 |
D/D |
(8,889) |
321,169 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-08-07 |
4 |
AS |
$6.08 |
$608,091 |
D/D |
(100,015) |
349,286 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-12-18 |
4 |
S |
$7.64 |
$2,170 |
D/D |
(284) |
46,342 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-12-19 |
4 |
S |
$7.73 |
$1,005 |
D/D |
(130) |
46,212 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-09-19 |
4 |
S |
$9.84 |
$1,279 |
D/D |
(130) |
46,626 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-09-18 |
4 |
S |
$9.91 |
$2,755 |
D/D |
(278) |
46,756 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-06-16 |
4 |
S |
$9.92 |
$2,807 |
D/D |
(283) |
47,164 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2023-06-20 |
4 |
S |
$10.30 |
$1,339 |
D/D |
(130) |
47,034 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-03-19 |
4 |
S |
$10.38 |
$1,349 |
D/D |
(130) |
27,391 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-03-18 |
4 |
S |
$10.71 |
$3,031 |
D/D |
(283) |
27,521 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-01-12 |
4 |
AS |
$10.95 |
$100,784 |
D/D |
(9,204) |
37,008 |
0 |
% |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-02-06 |
4 |
AS |
$13.70 |
$126,095 |
D/D |
(9,204) |
27,804 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-01-04 |
4 |
OE |
$40.63 |
$198,415 |
D/D |
4,307 |
11,867 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-10-03 |
4 |
OE |
$49.59 |
$38,581 |
D/D |
778 |
8,413 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-02-24 |
4 |
OE |
$49.65 |
$52,331 |
D/D |
1,054 |
12,277 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Vice President, Finance |
• – – |
2012-02-24 |
4 |
OE |
$49.65 |
$52,331 |
D/D |
1,054 |
6,939 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2010-12-01 |
4 |
D |
$65.37 |
$24,252 |
D/D |
(371) |
12,406 |
0 |
- |
|
100 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
